Join our Healthcare Private Practice Business Startup Masterclass to discover the essential steps, strategies, and tools needed to start and grow a successful healthcare practice.
Be among the first to learn about a clinical data related to cognition and behaviors for a newly approved treatment in Alzheimer’s disease.
Metabolic dysfunction-associated steatohepatitis (MASH), previously known as NASH, is a progressive liver disease closely linked to conditions such as obesity, type 2 diabetes, and dyslipidemia.
1: Innovations in Dyslipidemia Therapy and Cardiovascular Risk Reduction 2: Advancing Hypertension Care and Cardiovascular Risk Reduction through Guidelines, Risk Reduction, and Emerging Therapies 3: Herbal Remedies: Review of Commonly Used
Join us for this live symposium where leading neurotrophic keratitis (NK) experts will discuss the details of NK from pathophysiology and diagnosis to targeted therapies.
Join leading experts for an engaging discussion exploring the evolving science behind IgAN pathogenesis and treatment.
The GHAPP conference is the only conference specifically designed by advanced practice providers (APPs) for the purpose of meeting the educational needs of APPs who specialize in the management of patients with GI disorders and chronic liver disease.
Jumpstart provides a mix of Legal Nurse Consultant clinical, practice, business education and mentoring to start and grow your LNC career. You will receive 3 hours of on-demand content with 3 hours of live webinar with faculty and experienced LNCs.
Don't miss this opportunity to enhance your knowledge, ask top-of-mind questions, and harness new approaches to optimize DLBCL/FL care with bispecific antibodies.
Join us at AAFP-FMX 2025 for an interactive symposium featuring a panel of experts as they explore practical strategies to optimize the diagnosis, treatment, and prevention of uUTIs, while reviewing the latest data on emerging therapies in uUTI care.